Four out of 10 eczema patients struggle with sleep, and they may not volunteer that information unless you ask.

Rising demand for minimally invasive procedures, preventive aesthetics, and novel therapeutic uses position botulinum toxins ...

Designed to provide broad exposure to the Healthcare - Broad segment of the equity market, the Health Care Select Sector SPDR ...

AbbVie announced a significant expansion at its North Chicago facility, with plans to enhance U.S. production capacities for ...

In this week’s InnovationRx newsletter, we look at longevity drugs for dogs, programmable mRNA for fighting cancer, AI models ...

Announced updated Phase 2 data at ASCO for vilastobart, a tumor-activated, Fc-enhanced, anti-CTLA-4, demonstrating deep and ...

In July 2025, AbbVie announced a Phase 1/2 Study to Evaluate the Safety and Efficacy of AGN-193408 SR in Participants With ...

The leading Major Depressive Disorder Companies such as GH Research, Praxis Precision Medicines, AbbVie, Gedeon Richter, ...

Nexgel, Inc. (($NXGL)) has held its Q2 earnings call. Read on for the main highlights of the call. NEXGEL, Inc. recently held its earnings call, ...

The global High Potency API Contract Manufacturing Market is projected to grow from USD 10.5 billion in 2025 to USD 20.7 billion by 2035, registering a compound annual growth rate (CAGR) of 7.0%, ...

AbbVie will invest $195 million in its North Chicago, Illinois, manufacturing plant to expand domestic API production in the ...

AbbVie (ABBV) announced a $195 million investment in its North Chicago manufacturing facility to boost domestic API ...